Principal Technologies (FRA:JO7) ROE % Adjusted to Book Value : -37.65% (As of Oct. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Principal Technologies ROE % Adjusted to Book Value?

Principal Technologies's ROE % for the quarter that ended in Oct. 2024 was -235.29%. Principal Technologies's PB Ratio for the quarter that ended in Oct. 2024 was 6.25. Principal Technologies's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 was -37.65%.

Principal Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for Principal Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Principal Technologies ROE % Adjusted to Book Value Chart

Principal Technologies Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

ROE % Adjusted to Book Value

-52.31

Principal Technologies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-32.90	-73.32	-35.60	-30.28	-37.65

Competitive Comparison of Principal Technologies's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Principal Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Principal Technologies's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Principal Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Principal Technologies's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Principal Technologies ROE % Adjusted to Book Value Calculation

Principal Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-278.82%	/	5.33
	=	-52.31%

Principal Technologies's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-235.29%	/	6.25
	=	-37.65%

Principal Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Principal Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Principal Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Principal Technologies Inc (FRA:JO7) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3

Website

https://www.principal-technologies.com

Principal Technologies Inc focuses on investment in a healthcare technology company. It is building a diverse portfolio of investments in healthcare technology companies with a focus on those with distribution potential across the world, and have intellectual property capable of enhancing medical treatment, cost efficiency, optimizations of the patient pathway, and implementation of point-of-care technologies. The company operates in one reportable operational segment, being its operations in healthcare technology including the project management of international-scale clinical studies predominantly related to medical device technologies.

Principal Technologies Headlines

No Headlines